AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33866032 — intervention group
Group type: EXPERIMENTAL
Intervention: Berotralstat 150 mg
Number of subjects: 108
Study 33866032 — intervention group
Group type: EXPERIMENTAL
Intervention: Berotralstat 110 mg
Number of subjects: 108
Study 33866032 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Part 1)
Number of subjects: 108
Study 33220855 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (2·2 × 10^10 virus particles)
Number of subjects: 560
Study 33220855 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (standard-dose)
Number of subjects: 560
Study 33220855 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (single standard dose)
Number of subjects: 560
Study 33220855 — intervention group
Group type: COMPARATOR
Intervention: MenACWY (control)
Number of subjects: 560
Study 33252943 — intervention group
Group type: EXPERIMENTAL
Intervention: User-informed infographic (n = 75)
Number of subjects: 152
Study 33252943 — intervention group
Group type: COMPARATOR
Intervention: Standard EBT description (n = 77)
Number of subjects: 152
Study 35834139 — intervention group
Group type: EXPERIMENTAL
Intervention: Shoulder Control programme
Number of subjects: 627
Study 35834139 — intervention group
Group type: EXPERIMENTAL
Intervention: Knee Control programme
Number of subjects: 627
Study 35834139 — intervention group
Group type: COMPARATOR
Intervention: Control Group (usual training)
Number of subjects: 627
Study 33206054 — intervention group
Group type: EXPERIMENTAL
Intervention: fooya! dietary mobile game
Number of subjects: 104
Study 36366250 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular Rehabilitation (VR)
Number of subjects: 30
Study 36366250 — intervention group
Group type: COMPARATOR
Intervention: Conventional rehabilitation program
Number of subjects: 30
Study 32989491 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI)
Number of subjects: 336107
Study 34655319 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-operative manual correction of iliosacral dislocation of the sacroiliac joint
Number of subjects: 84
Study 34655319 — intervention group
Group type: COMPARATOR
Intervention: Standard THA protocol
Number of subjects: 84
Study 34198051 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone on, in holder
Number of subjects: 127
Study 34198051 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone off, in holder
Number of subjects: 127
Study 34198051 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone on, in pocket
Number of subjects: 127
Study 34198051 — intervention group
Group type: COMPARATOR
Intervention: Phone absent (control)
Number of subjects: 127
Study 32398642 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (24IU)
Number of subjects: 40
Study 32398642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 34369981 — intervention group
Group type: EXPERIMENTAL
Intervention: Single session of electronic cigarette vaping
Number of subjects: 0
Study 34369981 — intervention group
Group type: COMPARATOR
Intervention: Long-term tobacco cigarette or electronic cigarette use
Number of subjects: 0
Study 32260466 — intervention group
Group type: EXPERIMENTAL
Intervention: Schisandra Chinensis extract (1000 mg per day)
Number of subjects: 45
Study 32260466 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1000 mg of starch per day)
Number of subjects: 45
Study 33872802 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy for PTSD (IPT‐PTSD)
Number of subjects: 0
Study 33872802 — intervention group
Group type: COMPARATOR
Intervention: Prolonged Exposure (PE)
Number of subjects: 0
Study 33106171 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin capsules at a dose of 50 mg daily for a period of seven days
Number of subjects: 60
Study 33106171 — intervention group
Group type: COMPARATOR
Intervention: Standard therapeutic regimen for COVID-19
Number of subjects: 60
Study 33106171 — intervention group
Group type: COMPARATOR
Intervention: Melatonin-like placebo capsules at a dose of one capsule daily for a period of seven days
Number of subjects: 60
Study 33106171 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin and standard treatment
Number of subjects: 60
Study 33106171 — intervention group
Group type: COMPARATOR
Intervention: Placebo and standard treatment
Number of subjects: 60
Study 35271380 — intervention group
Group type: EXPERIMENTAL
Intervention: Infants receiving direct vitamin D supplementation (400 IU vitD3/day)
Number of subjects: 0
Study 35271380 — intervention group
Group type: COMPARATOR
Intervention: Infants receiving indirect vitamin D supplementation via mothers (mothers receiving 6,400 IU vitD3/day)
Number of subjects: 0
Study 33300311 — intervention group
Group type: EXPERIMENTAL
Intervention: Total laparoscopic nerve-sparing radical hysterectomy (TL-NSRH)
Number of subjects: 301
Study 33300311 — intervention group
Group type: COMPARATOR
Intervention: Open abdominal nerve-sparing radical hysterectomy (OA-NSRH)
Number of subjects: 301
Study 36458679 — intervention group
Group type: EXPERIMENTAL
Intervention: Desidustat 50 mg orally in a fasting state
Number of subjects: 0
Study 36458679 — intervention group
Group type: COMPARATOR
Intervention: Desidustat 50 mg orally in a fed state
Number of subjects: 0
Study 36458679 — intervention group
Group type: EXPERIMENTAL
Intervention: Desidustat 50 mg orally
Number of subjects: 0
Study 33180360 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ)
Number of subjects: 38
Study 35075017 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided bilateral erector spinae plane block (ESP block)
Number of subjects: 20
Study 35075017 — intervention group
Group type: COMPARATOR
Intervention: Thoracic Epidural Analgesia (TEA)
Number of subjects: 20
Study 34494517 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-fast track cardiac anaesthesia (Group D) with dexmedetomidine at 1 ?g/kg/hour and sufentanil for analgesia
Number of subjects: 130
Study 34494517 — intervention group
Group type: COMPARATOR
Intervention: Conventional anaesthesia (Group C) with normal saline and sufentanil for analgesia
Number of subjects: 130
Study 34494517 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-fast track cardiac anaesthesia (Group D)
Number of subjects: 130
Study 35148706 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) counseling in 8 sessions of 60 to 90 minutes
Number of subjects: 86
Study 35148706 — intervention group
Group type: COMPARATOR
Intervention: Routine health care (Control)
Number of subjects: 86
Study 35148706 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) counseling
Number of subjects: 86
Study 32822275 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (3 mg/kg intravenously every 2 weeks)
Number of subjects: 62
Study 32822275 — intervention group
Group type: COMPARATOR
Intervention: Nivolumab plus SBRT (9 Gy × 3 to 1 lesion)
Number of subjects: 62
Study 32822275 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 62
Study 35441435 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus diet
Number of subjects: 68
Study 35441435 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin only
Number of subjects: 68
Study 35441435 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin plus diet
Number of subjects: 68
Study 35441435 — intervention group
Group type: COMPARATOR
Intervention: Placebo only
Number of subjects: 68
Study 33376050 — intervention group
Group type: EXPERIMENTAL
Intervention: Greek IdFAI questionnaire (IdFAI-GR)
Number of subjects: 141
Study 34973306 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEP applied at 10 cmH20
Number of subjects: 80
Study 34973306 — intervention group
Group type: COMPARATOR
Intervention: No PEEP application (Control)
Number of subjects: 80
Study 36164101 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanubrutinib 160 mg twice daily
Number of subjects: 229
Study 36164101 — intervention group
Group type: COMPARATOR
Intervention: Ibrutinib 420 mg once daily
Number of subjects: 229
Study 36164101 — intervention group
Group type: EXPERIMENTAL
Intervention: Zanubrutinib
Number of subjects: 229
Study 36164101 — intervention group
Group type: COMPARATOR
Intervention: Ibrutinib
Number of subjects: 229
Study 34770227 — intervention group
Group type: EXPERIMENTAL
Intervention: Healing Beats program
Number of subjects: 99
Study 34770227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 34770227 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 99
Study 32164678 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally responsive best practice model of care including development of a best practice guide, education programs for health professionals, and decision support systems.
Number of subjects: 0
Study 32164678 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally responsive best practice model of care
Number of subjects: 0
Study 35833334 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (ESA) treatment
Number of subjects: 197
Study 35833334 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron treatment
Number of subjects: 197
Study 35833334 — intervention group
Group type: EXPERIMENTAL
Intervention: Four-variable iron preference score
Number of subjects: 197
Study 32291984 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical calcaneal external fixator designed based on morphological data of the heel.
Number of subjects: 100
Study 32291984 — intervention group
Group type: EXPERIMENTAL
Intervention: Ordinary configuration of the external fixator.
Number of subjects: 100
Study 32291984 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression configuration of the external fixator.
Number of subjects: 100
Study 32291984 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic configuration of the external fixator.
Number of subjects: 100
Study 35662232 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg/d for 12 weeks
Number of subjects: 37
Study 35662232 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ramipril)
Number of subjects: 37
Study 34881910 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 80
Study 35745238 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie-restricted (CR) diet for twelve weeks (n = 30)
Number of subjects: 60
Study 35745238 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 60
Study 34287695 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (open, endovascular, and stereotactic surgeries)
Number of subjects: 40285
Study 34287695 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (open surgery)
Number of subjects: 40285
Study 34287695 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (endovascular and stereotactic surgeries)
Number of subjects: 40285
Study 34287695 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (admissions involving interventions)
Number of subjects: 40285
Study 34287695 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (length of stay)
Number of subjects: 40285
Study 32075835 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 42
Study 34403561 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended learning
Number of subjects: 72
Study 34403561 — intervention group
Group type: COMPARATOR
Intervention: Conventional teaching
Number of subjects: 72
Study 33541457 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACYW-TT
Number of subjects: 918
Study 33541457 — intervention group
Group type: COMPARATOR
Intervention: MCV4-TT
Number of subjects: 918
Study 32602032 — intervention group
Group type: EXPERIMENTAL
Intervention: 68Ga‐DOTATATE PET‐CT
Number of subjects: 38
Study 32602032 — intervention group
Group type: COMPARATOR
Intervention: CI
Number of subjects: 38
Study 36107655 — intervention group
Group type: EXPERIMENTAL
Intervention: Distraction
Number of subjects: 0
Study 36107655 — intervention group
Group type: EXPERIMENTAL
Intervention: Reappraisal
Number of subjects: 0
Study 36107655 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural viewing
Number of subjects: 0
Study 34213978 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicaid expansion
Number of subjects: 196556
Study 32362166 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 300
Study 32362166 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 34116625 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention about the benefits of perceived control and planning for end-of-life
Number of subjects: 188
Study 34116625 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 188
Study 32196514 — intervention group
Group type: EXPERIMENTAL
Intervention: Microfinance and peer health leadership intervention
Number of subjects: 1258
Study 32196514 — intervention group
Group type: COMPARATOR
Intervention: Control condition (brief delayed intervention)
Number of subjects: 1258
Study 33544983 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium lactate mouthrinse prior to sodium fluoride mouthrinse
Number of subjects: 75
Study 33544983 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily mouthrinse with sodium fluoride
Number of subjects: 75
Study 33544983 — intervention group
Group type: COMPARATOR
Intervention: Control (absence of mouthrinse)
Number of subjects: 75
Study 33544983 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 75
Study 35360477 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal analgesic nursing
Number of subjects: 86
Study 35360477 — intervention group
Group type: COMPARATOR
Intervention: Routine analgesic nursing
Number of subjects: 86
Study 33656249 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflex zone stimulation (RST) for 30 minutes
Number of subjects: 21
Study 33656249 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 21
Study 36067240 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management intervention
Number of subjects: 151
Study 36067240 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 151
Study 32893767 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical exercise program (two 60-minute sessions per week for 36 weeks, supervised by a personal trainer)
Number of subjects: 48
Study 32893767 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical exercise program
Number of subjects: 48
Study 32893767 — intervention group
Group type: COMPARATOR
Intervention: Control group (habitual leisure-time activities)
Number of subjects: 48
Study 33269486 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 14565
Study 33208164 — intervention group
Group type: EXPERIMENTAL
Intervention: EFLT‐abolishing‐EPAP
Number of subjects: 12
Study 33208164 — intervention group
Group type: COMPARATOR
Intervention: Fixed‐EPAP
Number of subjects: 12
Study 34796778 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity KE strength-training
Number of subjects: 28
Study 34796778 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity KE strength-training
Number of subjects: 28
Study 34796778 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 34034754 — intervention group
Group type: EXPERIMENTAL
Intervention: artemether–lumefantrine (AL)
Number of subjects: 449
Study 34034754 — intervention group
Group type: EXPERIMENTAL
Intervention: artesunate–amodiaquine (ASAQ)
Number of subjects: 449
Study 32166842 — intervention group
Group type: EXPERIMENTAL
Intervention: Paresthesia mapping (PM)
Number of subjects: 53
Study 32166842 — intervention group
Group type: EXPERIMENTAL
Intervention: Anatomical placement (AP)
Number of subjects: 53
Study 35904639 — intervention group
Group type: EXPERIMENTAL
Intervention: NIR‐AF (Near-infrared autofluorescence)
Number of subjects: 60
Study 35904639 — intervention group
Group type: COMPARATOR
Intervention: Standard practice (Control)
Number of subjects: 60
Study 35904639 — intervention group
Group type: EXPERIMENTAL
Intervention: NIR‐AF
Number of subjects: 60
Study 32939028 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive trial designs
Number of subjects: 0
Study 32939028 — intervention group
Group type: EXPERIMENTAL
Intervention: Existing SCI registries
Number of subjects: 0
Study 32939028 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive methods
Number of subjects: 0
Study 35572982 — intervention group
Group type: EXPERIMENTAL
Intervention: CIT/HOMO (citicoline 500 mg plus homotaurine 50 mg) for 4 months
Number of subjects: 57
Study 35572982 — intervention group
Group type: COMPARATOR
Intervention: Topical therapy alone for 4 months
Number of subjects: 57
Study 33591774 — intervention group
Group type: EXPERIMENTAL
Intervention: Slower response speed
Number of subjects: 7565
Study 33591774 — intervention group
Group type: COMPARATOR
Intervention: Faster response speed
Number of subjects: 7565
Study 33591774 — intervention group
Group type: EXPERIMENTAL
Intervention: Explicit instructions to ignore response speed
Number of subjects: 7565
Study 32406864 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude letter-writing intervention (self-focused)
Number of subjects: 1575
Study 32406864 — intervention group
Group type: EXPERIMENTAL
Intervention: Gratitude letter-writing intervention (other-focused)
Number of subjects: 1575
Study 32406864 — intervention group
Group type: COMPARATOR
Intervention: Gratitude letter-writing intervention (self-focused vs other-focused)
Number of subjects: 1575
Study 32406864 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with higher motivation to improve EE
Number of subjects: 1575
Study 32406864 — intervention group
Group type: EXPERIMENTAL
Intervention: Linguistic analysis of gratitude letters
Number of subjects: 1575
Study 33979696 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual physiotherapy based on the Bobath concept, lasting about 60 min.
Number of subjects: 74
Study 33979696 — intervention group
Group type: COMPARATOR
Intervention: Lecture on the importance of trunk muscle stability and diaphragm position, lasting 45 min.
Number of subjects: 74
Study 32209449 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallium-68 PSMA-11 PET-CT
Number of subjects: 302
Study 32209449 — intervention group
Group type: COMPARATOR
Intervention: Conventional imaging (CT and bone scan)
Number of subjects: 302
Study 34473768 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sleep deprivation (n = 40)
Number of subjects: 60
Study 34473768 — intervention group
Group type: COMPARATOR
Intervention: Rested control condition (n = 20)
Number of subjects: 60
Study 32965617 — intervention group
Group type: EXPERIMENTAL
Intervention: CT-P13 (biosimilar infliximab)
Number of subjects: 155
Study 32965617 — intervention group
Group type: COMPARATOR
Intervention: Originator infliximab
Number of subjects: 155
Study 34587371 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal cyclosporine A for inhalation (L‐CsA‐i) administered twice daily via nebulizer for 2 years
Number of subjects: 130
Study 34587371 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal cyclosporine A for inhalation (L‐CsA‐i) administered to SLT recipients
Number of subjects: 130
Study 34587371 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered to BLT recipients
Number of subjects: 130
Study 33616260 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral aripiprazole
Number of subjects: 300
Study 33616260 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 300
Study 33616260 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 300
Study 33616260 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting antipsychotics
Number of subjects: 300
Study 33236124 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 0
Study 36099927 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab plus ipilimumab (nivolumab 1 mg/kg plus ipilimumab 3 mg/kg every 3 weeks for four doses followed by nivolumab 3 mg/kg every 2 weeks)
Number of subjects: 167
Study 36099927 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab alone (nivolumab 3 mg/kg every 2 weeks)
Number of subjects: 167
Study 36099927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study 34824169 — intervention group
Group type: EXPERIMENTAL
Intervention: lidocaine with dexmedetomidine 0.5 μg/kg
Number of subjects: 90
Study 34824169 — intervention group
Group type: EXPERIMENTAL
Intervention: lidocaine with dexmedetomidine 1 μg/kg
Number of subjects: 90
Study 34824169 — intervention group
Group type: COMPARATOR
Intervention: lidocaine diluted with normal saline
Number of subjects: 90
Study 33351126 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyvalent immunoglobulin preparation
Number of subjects: 0
Study 33351126 — intervention group
Group type: COMPARATOR
Intervention: Pneumolysin treatment
Number of subjects: 0
Study 33328218 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise 3 days/week for 12 weeks (n=28)
Number of subjects: 57
Study 33328218 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=29)
Number of subjects: 57
Study 32029304 — intervention group
Group type: EXPERIMENTAL
Intervention: Delgocitinib 0.5% ointment
Number of subjects: 100
Study 32029304 — intervention group
Group type: COMPARATOR
Intervention: Vehicle ointment
Number of subjects: 100
Study 35078486 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial shockwave on the carpal tunnel
Number of subjects: 60
Study 35078486 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial shockwave on the median nerve pathways
Number of subjects: 60
Study 35078486 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (Control)
Number of subjects: 60
Study 34185723 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mL 0.5% ropivacaine (low-volume STB)
Number of subjects: 0
Study 34185723 — intervention group
Group type: COMPARATOR
Intervention: 15 mL 0.5% ropivacaine (standard-volume STB)
Number of subjects: 0
Study 32014800 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care strategies and obstacles
Number of subjects: 46
Study 32014800 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of self-care
Number of subjects: 46
Study 33118702 — intervention group
Group type: COMPARATOR
Intervention: 0% chitosan supplementation
Number of subjects: 80
Study 33118702 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% chitosan supplementation
Number of subjects: 80
Study 33118702 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% chitosan supplementation
Number of subjects: 80